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Abstract
Background: Gluten proteins, prominent constituents of barley, wheat and rye, cause celiac disease in genetically
predisposed subjects. Gluten is notoriously difficult to digest by mammalian proteolytic enzymes and the protease-resistant
domains contain multiple immunogenic epitopes. The aim of this study was to identify novel sources of gluten-digesting
microbial enzymes from the upper gastro-intestinal tract with the potential to neutralize gluten epitopes.
Methodology/Principal Findings: Oral microorganisms with gluten-degrading capacity were obtained by a selective
plating strategy using gluten agar. Microbial speciations were carried out by 16S rDNA gene sequencing. Enzyme activities
were assessed using gliadin-derived enzymatic substrates, gliadins in solution, gliadin zymography, and 33-mer a-gliadin
and 26-mer c-gliadin immunogenic peptides. Fragments of the gliadin peptides were separated by RP-HPLC and structurally
characterized by mass spectrometry. Strains with high activity towards gluten were typed as Rothia mucilaginosa and Rothia
aeria. Gliadins (250 mg/ml) added to Rothia cell suspensions (OD620 1.2) were degraded by 50% after ,30 min of incubation.
Importantly, the 33-mer and 26-mer immunogenic peptides were also cleaved, primarily C-terminal to Xaa-Pro-Gln (XPQ)
and Xaa-Pro-Tyr (XPY). The major gliadin-degrading enzymes produced by the Rothia strains were ,70–75 kDa in size, and
the enzyme expressed by Rothia aeria was active over a wide pH range (pH 3–10).
Conclusion/Significance: While the human digestive enzyme system lacks the capacity to cleave immunogenic gluten, such
activities are naturally present in the oral microbial enzyme repertoire. The identified bacteria may be exploited for
physiologic degradation of harmful gluten peptides.
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Introduction
Celiac disease, an intestinal inflammatory disease with auto-
immune features, is caused by oral ingestion of gluten peptides that
escape intestinal degradation. These peptides are antigenically
presented on HLA-DQ2 or HLA-DQ8, preferentially after deam-
idation of certain glutamines by the celiac disease auto-antigen tissue
transglutaminase (tTG), eliciting a destructive Th1 T cell response
[1,2]. Gluten proteins that are found in wheat, barley and rye are
abundantly present in the Western diet. Strict elimination of gluten
from the diet is the therapy of choice, usually leading to a significant
improvement of clinical symptoms characteristic of celiac disease
related to malabsorption, fatigue and possibly associated autoimmu-
nity, and largely restores the duodenal mucosal damage (villous
atrophy, crypt hyperplasia, T cell infiltration). A strictly gluten-free
diet,however,isdifficulttomaintainandposesasignificantsocialand
financial burden to the patient. Therefore, an additive non-dietary
therapy that relieves patients from a highly restricted gluten free diet
is much needed [3,4].
A novel therapeutic approach for celiac disease is the use of
enzymes to achieve proteolytic fragmentation of gluten proteins
which otherwise escape proteolytic inactivation by gastric, pancre-
atic and intestinal brush border enzymes into smaller non-
immunogenic peptides. The resistance of gluten to digestive
proteases is due to a particular primary structure based on their
high number of proline (P) and glutamine (Q) residues, and
repetitive PQ sequences that are not cleavable by common GI
proteases [5]. A 33-mer peptide present in a-gliadins [6] (also
denoted as ‘‘superantigen’’ [7]), and a 26-mer peptide from c-
gliadins [8] are particularly resistant to degradation, while carrying
multiple potent HLA-DQ2 binding T cell stimulatory epitopes after
deamidation by tTG [9]. Abolishment of these and related peptides
by proteolyticenzymes, e.g.providedasa dietarysupplement,could
conceivably reduce immunotoxicity of gluten for celiac patients
[10].
A number of gluten-degrading enzymes from microbial and
cereal sources have been discovered. Prolyl-endopeptidases target
the conformationally constrained peptide bonds C-terminal to
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Flavobacterium meningosepticum, Myxococcus Xanthus and Aspergillus niger
have been pursued as drug candidates for enzymatic treatment of
gluten in celiac disease [11,12]. Another enzyme with such
therapeutic potential is a glutamine endoprotease from barley
designated EP-B2 [13]. Prolyl endopeptidases, alone or in
combination with EP-B2, have been demonstrated to neutralize
immunotoxicity of a pre-digested gluten preparation in vitro, ex vivo
and in vivo [14,15,16,17,18]. While promising in terms of gluten-
degrading activities, all enzymes referred to above originate from
species not naturally associated with the human body. In addition,
toxicity of F. meningosepticum and A. niger limits their usefulness as
probiotic agents.
A biologically more favorable and likely source for gluten-
degrading enzymes would be the microbiome colonizing the
human gastro-intestinal tract. It is well recognized that bacteria
populating the human body supply the host with numerous
functions that are not encoded by the human genome [19]. For
instance, bacteria that colonize the large intestine ferment starches
that are resistant to mammalian digestive enzymes [20]. Recent
work in our laboratory has shown that gluten-degrading bacteria
are naturally residing in the oral cavity [21,22]. The discovery of
oral enzymes with such activities is significant, since the oral cavity
represents the entrance to the digestive tract that all ingested
food has to pass and in which gluten is mixed with the oral
microorganisms in human saliva. The finding of gluten-degrading
oral microbes may serve as a novel source for therapeutic gluten
degrading enzymes. In this study we isolated and identified gluten-
degrading microorganism(s) from human saliva and plaque
samples and functionally characterized the enzymes with regard
to their capacity to degrade immunogenic gliadin peptides.
Materials and Methods
Collection of dental plaque and whole saliva samples
This study, involving the collection of human dental plaque and
whole saliva, was approved by the Institutional Review Board at
Boston University, protocol number H-23709. Written informed
consent was obtained from the participating subject prior to
participation. The enrolled subject presented with good oral health
without overt signs of gingival inflammation or other oral or sys-
temic conditions. Supragingival plaque was collected from inter-
proximal dental spaces with an explorer 24 h after refraining from
oral hygiene. The plaque material was suspended in 500 ml saliva
ion buffer containing 50 mM KCl, 1.5 mM potassium phosphate,
1 mM CaCl2 and 0.1 mM MgCl2, pH 7.0. Masticatory stimulated
whole saliva (5 ml) was obtained by expectoration as described [23].
Culturing of oral microorganisms
Aliquots of 50 ml of 1:1,000 diluted dental plaque or whole saliva
suspensions were plated on gluten-limited agar (GA) containing per
liter: 23 g wheat gluten (Sigma-Aldrich, St. Louis, MO; catalog
number G5004, .80% protein), 5 g sodium chloride (Fisher,
Pittsburg, PA), 1 g soluble starch (Fisher), 12 g agar (Fluka, Sigma-
Aldrich), 0.4 g sodium bicarbonate (Fisher), 1 g glucose (Sigma-
Aldrich), 1 g sodium pyruvate (Sigma-Aldrich), 0.5 g cysteine
(Sigma-aldrich), 0.01 g haemin and 0.001 g vitamin K (Beckton-
Dickinson, Franklin Lakes, NJ), 1 g L-arginine (Sigma-Aldrich),
0.25 g soluble pyrophosphate (Fisher) and 0.5 g sodium succinate
(Fisher). Incubations were carried out at 37uC under aerobic
conditions or in a sealed candle jar that was rendered anaerobic
using GasPak pouches (Beckton-Dickinson, Franklin Lakes, MD).
Individual colonies were transferred to GA plates and after 48
incubation were subcultured on Brucella agar (Hardy Diagnostics,
Santa Maria, CA). Subculturing on Brucella agar plates was repeated
until cultures were obtained that were macroscopically and
microscopically pure. The strains were then plated once more on
GA to confirm growth on this selective agar formulation. From
these slabs bacterial stocks were prepared which were kept at
280uC in a glycerol/BHI broth mixture (20/80% v/v).
Microbial speciation by 16S rDNA
Microbial colonies with gliadin-degrading activity were identified
by 16S rDNA analysis. DNA extraction was performed using the
UltraClean
TM Microbial DNA Isolation Kit (Mo Bio Laboratories,
Carlsbad, CA) following the manufacturer’s instructions for the
isolation of genomic DNA from Gram-positive bacteria. Purified
DNA was sequenced using an ABI prism cycle-sequencing kit
(BigDyeH Terminator Cycle Sequencing kit) on an ABI 3100
Genetic Analyser (Applied Biosystems, Foster City, CA). Reactions
used a quarter-dye chemistry as previously described [24,25].
Partial sequences were identified by BLASTN analysis against the
Human Oral Microbiome Database (http://www.homd.org) con-
taining sequencing of over 35,000 clones and isolates. Sequences
were assembled from the ABI electropherogram files using
Sequencher 4.9 (Gene Codes Corporation, Ann Arbor, MI).
Degradation of paranitroanilide-derived substrates
The hydrolysis of four gliadin-derived substrates, benzyloxy-
carbonyl-YPQ-paranitroanilide (Z-YPQ-pNA), Z-QQP-pNA, Z-
PPF-pNA and Z-PFP-pNA, was assessed spectrophotometrically at
405 nm as described previously [22].
Degradation of gliadins in-solution
A mixture of gliadins was purchased from Sigma (St. Louis,
MO), dissolved to 5 mg/ml in 60% (v/v) ethanol and diluted to
250 mg/ml in suspensions of bacterial strain WSA-8 (R. aeria; final
OD620 1.0). Incubation mixture aliquots (100 ml) were removed
after various incubation times, dried and analyzed on pre-cast
12% gels (Novex, InVitrogen, Carlsbad, CA).
Degradation of 33-mer and 26-mer gliadin domains
Synthetic highly immunogenic peptides derived from a2-gliadin
(LQLQPFPQPQLPYPQPQLPYPQPQLPYPQPQPF; 33-mer)
[6] or c-gliadin (FLQPQQPFPQQPQQPYPQQPQQPFPQ; 26-
mer) [8] were synthesized at a purity of 95% (21
st Century
Biochemicals, Marlboro, MA), dissolved in deionized water to
10 mg/ml. The peptides (final concentration 250 mg/ml) were
incubated with trypsin or chymotrypsin (1 mg/ml in 50 mM
ammonium bicarbonate, pH 8.0), or pepsin (1 mg/ml in 0.1 M
HCl, pH 1.0) or strain WSA-8 (R. aeria) in saliva ion buffer (OD620
1.2, pH 7.0). Degradation of the 33-mer and 26-mer over time
was monitored in 100 ml aliquots by RP-HPLC as reported
previously [22].
RP-HPLC
The 100 ml sample aliquots were mixed with 900 ml buffer A
containing 0.1% (v/v) trifluoroacetic acid (TFA), filtered and
analyzed by RP-HPLC using a HPLC Model 715 (Gilson,
Middleton, WI) and a C-18 column (TSK-GEL 5 mm, ODS-
120T, 4.66250 mm, TOSOHaas, Montgomeryville, PA). Pep-
tides were eluted using a linear gradient from 0% to 55% buffer B
containing 80% (v/v) acetonitrile and 0.1% (v/v) TFA over a
75 min time interval at a flow rate of 1.0 ml/min. The eluate was
monitored at 219 and 230 nm and eluting fractions were collected
using peak width and peak sensitivity settings of 1.2 and 5,
respectively (Unipoint version 3.3, Gilson). The collected peaks
Rothia Bacteria Degrading Dietary Gluten
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Waltham, MA).
Mass Spectrometric Characterization of 33-mer/26-mer
fragments by LC-ESI-MS/MS
All dried peaks were dissolved in 25 ml of a solution containing
5% acetonitrile and 0.1% formic acid. Mass spectrometry was
conducted using a capillary nano-flow liquid chromatography and
electrospray ionization tandem mass spectrometer (LC-ESI-MS/
MS) as previously described [22,26]. The raw MS/MS data of the
peptide ions in each of the analyzed samples were searched against
an in-house generated database containing the sequences of the
33-mer and the 26-mer using SEQUEST software (Bioworks
Browser 3.3.1, Thermo-Finnigan). X-corr values applied were 1.5,
2.2 and 3.5 for Z=1, 2, and 3, respectively. The deltaCn and
peptide probability values were set at .0.1 and ,0.01 which
avoided false-positive identifications as reported. [22]
Gliadin zymography
Bacterial strains WSA-2B (R. mucilaginosa), WSA-8 (R. aeria),
WSA-26 (R. mucilaginosa)a n dR. mucilaginosa ATCC 25296 were
harvested from Brucella agar and suspended in saliva ion buffer to a
final OD620 of 5.0. A 150 ml aliquot was centrifuged, the cell pellet
resuspended in 20 ml zymogram sample buffer and analyzed by
gliadin zymography as described [22] except that the separating gel
contained 6% instead of 8% acrylamide to achieve a better
separation of proteins in the 70–75 kDa region.
Results
Isolation and speciation of gluten-degrading oral
bacteria
Oral microorganisms capable of degrading gluten were
obtained by plating on gluten-limited agar plates (GA). Bacterial
colonies were subcultured on Brucella agar to purity and further
subcultured on GA to verify growth on this selective agar.
Figure 1A shows an example of a segmented GA plate with 20
colonies subcultured from Brucella agar plates. One strain,
indicated with an arrow, grew rapidly on GA. In control
experiments, the strains were cultured on agar plates that
contained all the ingredients of GA except wheat gluten
(Figure 1B). The lack of growth on this agar formulation indicates
that gluten is an essential ingredient facilitating growth. By this
selective plating strategy, 27 aerobic and 30 anaerobic oral strains
capable of metabolizing gluten were obtained. Microbial specia-
tion of the fastest growing strains (5 aerobic and 10 anaerobic
strains) was carried out by 16S rDNA analysis. The DNA typing
results revealed that some of the strains represented the same
genus. For instance, strains WSA-2B and WSA-26 were both
typed as Rothia mucilaginosa ot 681. Strain WSA-8 also belonged to
the Rothia genus, representing Rothia aeria ot 188 (formerly denoted
as Rothia sp. ot 188; www.homd.org). Strain WSA-7A was
identified as Streptococcus mitis ot 677 and WSA-10 as Staphylococcus
epidermis ot 601. All anaerobic strains belonged to the Bifidobacterium
genus: strains WSAN-14, -16, and -24 were typed as Bifidobacterium
longum ATCC 15697; and strains PAN-5, -8, -18, and -19 were
identified as Bifidobacterium dentium ot 588.
Hydrolysis of paranitroanilide-derivatized substrates
The tripeptides YPQ, QQP, PPF and PFP occur with high
frequency in gluten sequences. In our earlier work we have
demonstrated that mixed human dental plaque bacteria cleave Z-
YPQ-pNA, Z-QQP-pNA, Z-PPF-pNA and Z-PFP-pNA [22].
Here we investigated if the 15 oral strains selected on GA would
cleave these pNA-derivatized substrates (Table 1). In the aerobic
category, R. mucilaginosa and R. aeria efficiently hydrolyzed Z-YPQ-
pNA. Some activity was observed for Streptococcus mitis whereas
Staphylococcus epidermis was inactive. In contrast to Z-YPQ-pNA, the
substrates Z-QQP, Z-PPF-pNA and Z-PFP-pNA were not
cleaved. The anaerobic bifidobacteria were unable to cleave any
of the four gliadin-derived substrates.
For two of the aerobic strains, WSA-2B (R. mucilaginosa)a n d
WSA-8 (R. aeria) cleavage kinetics were established towards Z-YPQ-
pNA and another substrate of the XPQ type, namely Z-KPQ-pNA.
Both substrates were hydrolyzed in a cell-density and time-
dependent manner (Figure 2). At the highest cell densities evaluated
(OD620 1.2), R. mucilaginosa virtually completely hydrolyzed Z-YPQ-
pNA and Z-KPQ-pNA after 360 min while R. aeria completed the
cleavage of these substrates after 180 min and 60 min, respectively.
Overall, the results reveal rapid, cell density dependent, enzyme
kinetics for both Rothia strains. Cleavage of Z-YPQ-pNA as well as
Z-KPQ-pNA indicates protease cleavage after PQQ and little
Figure 1. Assessment of bacterial growth on gluten-limited agar. Twenty different microbial strains collected from dental plaque were
cultured on agar media containing gluten as the sole protein source (GA, left) and on the same agar formulation not containing gluten (control,
right). After 24 h incubation, among these twenty analyzed strains, one strain (WSA-8) was found to be capable of growing on the gluten agar
(indicated by an arrow). Note the presence of small, undissolved gluten particles appearing as white flakes in the gluten agar.
doi:10.1371/journal.pone.0024455.g001
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recognition.
Gliadin degradation in solution
The actual degradation of gliadin by oral bacteria was
investigated by incubating gliadins in a suspension of strain WSA-
8( R. aeria). Aliquots were removed from the incubation mixture at
the indicated time points and analyzed by SDS-PAGE (Figure 3).
We previously reported that the major protein in the gliadin
preparation, exhibiting a molecular weight of approximately
37 kDa, is degraded, although at a fairly low rate, in a suspension
of mixed dental plaque [22]. Gliadins were however rapidly cleaved
in a suspension of R. aeria, as evidenced from the finding that within
2 h of incubation the added amount of gliadin (250 mgi na1m l
volume) was completely degraded (Figure 3A). The precise time
course for gliadin degradation by R. aeria was established in a
separate experiment in which sampling was carried out at shorter
time intervals within the 2 h incubation time period (Figure 3B).
Approximately 50% of the added gliadin amount was degraded in
,30 minutes. Similar degradation kinetics were observed when
gliadins were incubated in a suspension of strain WSA-2B (data not
shown). These results demonstrate that Rothia species are highly
effective in degrading gluten and that their activities far exceed the
activities present in mixed dental plaque.
Comparison of proteolytic degradation of the 33-mer
and 26-mer by mammalian enzymes and by R. aeria
The a-gliadin derived 33-mer peptide as well as the c-gliadin
derived 26-mer peptide are resistant to degradation by mammalian
enzymes [6,8] which we confirmed experimentally (Figure 4A, B,
C). In parallel experiments, the peptides were incubated in a cell
suspension of strain WSA-8 (R. aeria). Both the 33-mer and 26-mer
peptide are rich in XPQ sequences, putatively targeted by the Rothia
enzymes. Results show the rapid degradation of the 33-mer by R.
aeria (Figure 4D) as evidenced from the disappearance of the 33-mer
peptide over the 2 h time interval and the concomitant appearance
of degradation fragments eluting earlier in the chromatogram. The
26-mer peptide was also sensitive to proteolytic degradation (Figure
S1). The data indicate a dramatic difference in proteolytic capacity
ofmammaliandigestiveenzymesversusRothiaproteasestowardsthe
gliadin regions implicated in celiac disease.
Determination of cleavage site specificity of R. aeria
towards the 33-mer
Immunogenic epitopes contained within the 33-mer peptide
include glia-a9 (LQLQPFPQPQLPY) and glia-a2 (PQPQLPY-
PQPQLPY), and in the 26-mer peptide glia-c2 (PFPQQPQQP) and
PYPQQPQQP [27]. It is of importance to determine if the Rothia
enzymescouldcleaveintheseparticulardomains.RP-HPLCanalysis
of the fragmentation cascade of the 33-mer in a cell suspension of
WSA-8(R.aeria) is shown in Figure 5A. The intact 33-mer eluted after
66 min (t=0 sample, peak off scale). In the t=2 h and 5 h samples
the 33-mer was completely cleaved proteolytically. Degradation
fragments in peaks 1 to 11 were collected and structurally chara-
cterized by LC-ESI-MS/MS analysis (Figure 5B). From the N- and
C-terminiof thesepeptides, the enzymatic cleavage site specificities of
the Rothia-associated enzymes could be derived. Consistent with
noted XPQ-pNA hydrolysis, prominent cleavage was observed after
QPQQ. Repeated cleavage was also noted after LPY. This novel
protease specificity was confirmed with the synthetic enzymatic
substrate Z-LPY-pNA (data not shown). Most degradation fragments
had arisen through cleavage at QPQQ and/or LPYQ with
occasional cleavage at other positions. Some fragments in the 2 h
sample (i.e. those eluting in peaks 9 and 10) disappeared in the 5 h
sample, indicative of continued cleavage as time progressed.
Table 1. Enzymatic characteristics of selected oral microorganisms cultured on gluten agar.
Aer/Anaer Strain ID GenBank Accession Strain name
a Hydrolysis of gluten-based substrates
b
YPQ QQP PPF PFP
Aerobic WSA-2B JF895494 Rothia mucilaginosa HOT-681 +++ 222
WSA-7A JF895495 Streptococcus mitis HOT-677 +/2 222
WSA-8 JF895496 Rothia aeria HOT-188 +++ 222
WSA-10 JF895497 Staphylococcus epidermidis HOT-601 2222
WSA-26 JF895498 Rothia mucilaginosa HOT-681 +++ 222
Anaerobic WSAN-14 JF895499 Bifidobacterium longum HOT-B54 2222
WSAN-16 JF895500 Bifidobacterium longum HOT-B54 2222
WSAN-24 JF895501 Bifidobacterium longum HOT-B54 2222
WSAN-25 JF895502 Veilonella atypica HOT-524 2222
PAN-0 JF895503 Streptococcus pneumoniae HOT-734 2222
PAN-5 JF895504 Bifidobacterium dentium HOT-588 2222
PAN-8 JF895505 Bifidobacterium dentium HOT-588 2222
PAN-18 JF895506 Bifidobacterium dentium HOT-588 2222
PAN-19 JF895507 Bifidobacterium dentium HOT-588 2222
PAN-23 JF895508 Bifidobacterium dentium HOT-588 2222
Aer+Anaer Whole plaque Mixture of bacteria +++ +++ +++ +++
aSpeciation was carried out by partial 16S rDNA gene sequencing. All sequences were greater than 99% similar reference sequences at the Human Oral Microbiome
Database (www.homd.org).
bSubstrates (final concentration 200 mM) were mixed with bacterial suspensions in saliva ion buffer (OD620 1.2). Hydrolysis was measured spectrophotometrically at
405 nm after 24 h incubation.
doi:10.1371/journal.pone.0024455.t001
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R. mucilaginosa ATCC 25296 (not shown). As for R. aeria,X P Q Q and
LPYQ were the prominent protease target sites for R. mucilaginosa.
Overall, R. aeria and R. mucilaginosa enzymes cleave the antigenic 33-
mer peptide in domains that contain the major a-gliadin epitopes.
Determination of cleavage site specificity of R. aeria
towards the 26-mer
The proteolytic fragmentation cascade of the 26-mer by WSA-8 (R.
aeria)-associated proteases is shown in supplemental Figure S2. R. aeria
as well as R. mucilaginosa cleaved the 26-mer peptide after XPQ as well
as other glutamine (Q) residues along the 26-mer sequence. In
addition,QPYwascleaved,possiblybythe same enzyme(s)recognizing
LPY in the 33-mer peptide. In analogy to observations made with the
33-mer peptide, it can be concluded that Rothia enzymes targeted
regions in the 26-mer containing the essential c-gliadin epitopes.
Determination of enzyme molecular weights by gliadin
zymography
The next series of experiments were designed to gain more
insight into structural characteristics of the gluten degrading
enzymes. To establish the approximate molecular weight of the
enzymes strains WSA-2B (R. mucilaginosa), WSA-8 (R. aeria)a n d
WSA-26 (R. mucilaginosa) as well as reference strain, R.
mucilaginosa ATCC 25296 were analyzed by gliadin zymogra-
phy. All four strains expressed gliadin-degrading enzymes which
appeared as clear bands in the zymogram gel developed at
pH 7.0 (Figure 6A). As expected, the protease patterns of the R.
mucilaginosa strains were very similar, showing a major double
band in the 75 kDa region. Activity was also noted in higher
(,150 kDa) molecular weight regions, perhaps representing
dimeric forms of the 75 kDa enzymes. R. aeria displayed one
prominent protease band with an electrophoretic mobility
around 70 kDa.
pH activity analysis
To determine protease activities under conditions that are
representative of the stomach, the zymogram gel with the four
Rothia strains was also developed at pH 3.0 (Figure 6B). At this pH
value the R. mucilaginosa enzymes were virtually inactive. In
contrast, strain R. aeria showed a weak but distinct band with
enzymatic activity in the zymogram. To further investigate the pH
range over which strain R. aeria was active, Z-YPQ-pNA substrate
hydrolysis was measured in solutions ranging in pH from 2.0 to
10.0. Optimal enzyme activities were observed at pH.7.0
(Figure 6C). Substrate hydrolysis rates decreased in parallel with
decreasing pH values from pH 7.0 to pH 4.0. At pH 3.0 substrate
cleavage was noted only after 72 h incubation. The slow but
Figure 2. Relationship between cell density and proteolytic activity. WSA-2B (R. mucilaginosa) or WSA-8 (R. aeria) cells were suspended in
saliva ion buffer to a final cell concentration of OD620 0.15, 0.3, 0.6, and 1.2. Z-KPQ-pNA or Z-YPQ-pNA were added as enzymatic substrates to a final
concentrations of 200 mM. Note that the rate of substrate hydrolysis increased with increasing cell density. As expected, boiled cell suspensions
(OD620 1.2) were devoid of enzyme activities.
doi:10.1371/journal.pone.0024455.g002
Rothia Bacteria Degrading Dietary Gluten
PLoS ONE | www.plosone.org 5 September 2011 | Volume 6 | Issue 9 | e24455noticeable enzyme activity of R. aeria at this pH value is consistent
with the gliadin zymogram results presented in Figure 6B. At
pH 2.0, however, no Z-YPQ-pNA hydrolysis could be observed
and protease activities could not be reactivated upon transfer to
neutral pH values (data not shown), suggesting irreversible
inactivation of the enzyme under these conditions.
Figure 3. Degradation of gliadins by R. aeria. Gliadin (250 mg/ml) was incubated in a suspension of WSA-8 (R. aeria). The final OD620 was 1.0.
Incubation sample aliquots were analyzed by Bis-Tris PAGE. A, lane 1: molecular weight standard; lanes 2–7, WSA-8/gliadin mixtures incubated for 0,
2, 4, 6, 24 and 48 h, respectively. B, lane 1: molecular weight standard, lanes 2–7: WSA-8/gliadin mixture incubated for 0, 5, 15, 30, 60 and 120 min,
respectively. Lanes 8 and 9: gliadins incubated for 0 and 120 min in boiled bacterial cell suspensions; lanes 10 and 11: cell suspensions without added
gliadins; Lanes 12 and 13: gliadins incubated for 0 and 120 min in saliva ion buffer only. Arrow points to the major protein constituent in the gliadin
mixture.
doi:10.1371/journal.pone.0024455.g003
Figure 4. Degradation of the 33-mer by mammalian enzymes and by enzymes associated with R. aeria. The 33-mer peptide was
incubated with pepsin (A), trypsin (B), chymotrypsin (C) (each 1 mg/ml) sampled at t=0 and t=24 h or in a suspension of WSA-8 (R. aeria) cells (D;
OD620 1.2) sampled at t=0, 30 min, 60 min and 120 min. Degradation of the 33-mer in incubation aliquots was monitored by RP-HPLC.
doi:10.1371/journal.pone.0024455.g004
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The present study has uncovered specific microorganisms in
mixed dental plaque that display potent gluten-degrading activity.
The most efficient cleaving strains were identified as Rothia
mucilaginosa and Rothia aeria. The data present evidence that even in
the absence of gliadin pretreatment with mammalian digestive
enzymes, gliadins (and by inference glutens) serve as a good
substrate for Rothia associated bacterial enzymes and are rapidly
cleaved. Importantly, major immunogenic epitopes that play a key
role in celiac disease are also targeted by Rothia enzymes. The
colonization of the oral cavity with microorganisms that produce
glutamine endoproteases may not be surprising given that salivary
proline-rich proteins as well as dietary wheat gluten proteins are
prominent and abundant substrates in the oral cavity and an
important factor in driving microbial colonization is nutrient
substrate availability. The observations made suggest that Rothia
bacteria may contribute to the digestive processing of immuno-
genic gluten proteins.
The human body is a major reservoir of a wide variety of
microorganisms and their contribution to overall health and well-
being of the host, including aspects of digestion, become more
and more recognized [28]. The human microbiome project, a
multidisciplinary international research initiative, is aimed at
characterizing the microbial composition of the entire human
body [29]. Among all human organ- and body-site specific
microbiomes, the oral microbiome has been characterized most
extensively (accessible at www.homd.org) [30]. The known
microbiome of the oral cavity and its anatomically contiguous
regions to date contains 619 taxa, derived from 13 phyla:
Recently, an additional 36,043 gene clones were sequenced,
identifying an additional 434 novel oral taxa which are candidates
Figure 5. Degradation and fragment analysis of the 33-mer incubated with R. aeria. Gliadin 33-mer (250 mg/ml) was incubated in a
suspension of WSA-8 (R. aeria) cells (OD620 1.2). Incubation aliquots removed after 0 h, 2 h and 5 h were analyzed by RP-HPLC (A). Degradation peaks
labeled 1 to 11 were collected and sequenced by LC-ESI-MS/MS (B). Large arrows: cleavage after QPQ; small solid arrows: cleavage after LPY; small
dotted arrows: other cleavages.
doi:10.1371/journal.pone.0024455.g005
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microbial clones sequenced to date, R. mucilaginosa ot 681 and
R. aeria ot 188 rank at #170 and #221 in order of abundance.
Evidently, the selective GA plating approach applied in our study
has significantly enriched for the Rothia bacteria in the mixed oral
samples.
R. mucilaginosa and R. aeria belong to the Rothia genus under the
Actinobacteria phyla. Rothia species are Gram-positive bacteria,
ovoid in shape and form clusters of cocci. R. aeria, named after its
isolation from air in the Russian space laboratory Mir [32], is an
oral colonizer [31]. R. mucilaginosa also primarily colonizes the oral
cavity [33] but has furthermore been isolated from other body
sites, including the upper respiratory tract and the duodenum
[34,35,36]. Colonization of the duodenum with gluten-degrading
Rothia species is of particular interest in view of the fact that
mucosal damage in celiac disease is largely restricted to this region
of the GI tract. Bacterial speciation of 2,247 clones recovered from
63 duodenal biopsies obtained from healthy and celiac patients
showed that R. mucilaginosa comprised ,6% of the clones and was
present in ,65% of the biopsies, identifying it as a true colonizer
of the duodenum [36]. No significant differences were found in the
number of R. mucilaginosa clones from healthy and celiac patients
(6.5% and 5.9% of clones, respectively). Likewise, the percent of
healthy and celiac biopsies being positive for R. mucilaginosa did not
differ significantly from each other (64% and 67%, respectively)
[36]. It thus appears that R. mucilaginosa colonizes the healthy and
celiac-afflicted duodenum to the same extent. It will be of interest
to also investigate Rothia concentration differences in human saliva
in view of the fact that the microbial colonization levels in the oral
cavity far exceed those of the duodenum, and a large volume of
saliva is swallowed each day (approximately 0.8–1.0 L).
The discovery of salivary microorganisms degrading dietary
proteins in vitro prompts the question to what extent such
microorganisms play a role in food processing in vivo. During
mastication (chewing) foods are mixed with whole saliva helping to
accelerate the break-down by digestive enzymes during the
residency time in the oral cavity. Oral microorganisms in the
swallowed food bolus may or may not survive and/or continue to
exert proteolytic activities during or after gastric passage. Our in
vitro data with R. aeria show that its enzymes are not abolished at
acidic pH values, and are optimally active under more basic pH
conditions. In vivo, this could mean that during gastric passage the
enzymes will neither be active nor destroyed, and that enzymatic
reactivation would occur upon transfer to the duodenum. With
Figure 6. Gliadin zymography (6%) of Rothia strains and pH activity analysis. In the zymogram gels 150 ml cells (OD620 5.0) were applied per
lane. Lane 1, strain WSA-2B (R. mucilaginosa); lanes 2: strain WSA-8 (R. aeria), lane 3: strain WSA-26 (R. mucilaginosa); lane 4: strain ATCC 25296
(R. mucilaginosa). A, gel developed at pH 7.0; B, gel developed at pH 3.0. C, Z-YPQ-pNA (200 mM) hydrolysis by WSA-8 cells (OD620 1.2) measured in
20 mM Tris solutions ranging in pH from 2.0 to 10.0. Measurements at 405 nm were carried out hourly for the first 6 hours and after 24 h and 72 h.
doi:10.1371/journal.pone.0024455.g006
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mucilaginosa gains a foothold in the duodenum [36]. This offers the
intriguing possibility that Rothia may colonize the duodenum and
perform proteolytic activities locally in conjunction with mamma-
lian-derived enzymes to degrade gluten.
From a therapeutical perspective, the identified Rothia enzymes
differ in three major aspects from the major glutenase enzymes
that are currently being tested in clinical trials (SC-PEP and EP-
B2; Alvine Pharmaceuticals, and AN-PEP; DSM). First, the
enzyme source is a resident human body-associated oral
commensal bacterium. Second, the cleavage site specificity of
the Rothia enzymes is unique in that they cleave XPQQ as well as
LPYQ. The latter cleavage specificity is not exerted by prolyl
endopeptidases, which hydrolyze peptide bonds C-terminal to
proline residue [11,12]), and is also not observed for EP-B2 [13].
Thus the Rothia specificities supplement those of enzymes under
investigation for celiac disease therapy. Cleavage after the LPYQ
tripeptide is highly relevant since it is present in three copies
throughout the immunogenic 33-mer sequence. The third feature
that sets the Rothia enzymes apart is their wide pH activity range
spanning from pH 4.0 (appreciable activity) to pH 10.0. While at
this stage of our investigation we are unable to assign the activity to
one or to several enzymes in the Rothia cell suspension, the
potential of Rothia to serve as a valuable natural source of gluten-
degrading enzymes is demonstrated.
With regard to the suggested in vivo usefulness of the Rothia
enzymes as a treatment for celiac disease, it is imperative to
establish if gliadin fragmentation by Rothia is beneficial or harmful
to the host, in particular, to the celiac host. While immunogenic
domains in the a-2, a-9 and c-gliadin epitopes were cleaved by the
Rothia enzymes, digestion of these regions by Rothia was incomplete
as evidenced by the finding that by-products of the digestion still
contained immunogenic peptide sequences such as QLQPFP-
QPQLPY [37], PFPQPQLPY and PQPQLPYPQ [7] (Figure 5B
and Figure S2B). By virtue of their smaller size, these peptides may
reach the lamina propria more easily than larger immunogenic
fragments [38]. Furthermore, most of the degradation fragments
identified are theoretically of sufficient length to bind to HLA-
DQ2 after deamidation by tissue transglutaminase [39], an
essential step in the pathway towards T-cell activiation [40]. To
test this, we measured TG2-mediated cross-linking of peptides in
the Rothia-33-mer and Rothia-26-mer degradation mixtures to
monodansyl cadaverine as a measure for deamidation and T cell
stimulatory potential. A surprisingly strong correlation was
observed between 33-mer or 26-mer degradation and loss of TG
crosslinking. These results indicated that the degradation frag-
ments are not good substrates for deamidation by TG2, suggesting
loss of immunotoxicity [41]. T-cell proliferation assays are planned
to validate these observations.
Gluten-degrading microorganisms in the GI tract may play a
hitherto unappreciated role in the digestion/detoxification of
dietary gluten. They open promising new avenues in the search for
novel therapies to neutralize the deleterious effects of gluten in
patients with celiac disease. Furthermore, to exploit these bacteria
or their enzymes is highly attractive, since they belong to the
normal flora of the upper GI tract.
Supporting Information
Figure S1 Degradation of the 26-mer by mammalian enzymes
and by enzymes associated with R. aeria. The 26-mer peptide was
incubated with pepsin (A), trypsin (B), chymotrypsin (C) (each
1 mg/ml) sampled at t=0 and t=24 h or in a suspension of WSA-
8( R. aeria) cells (D; OD620 1.2) sampled at t=0, 30 min, 60 min
and 120 min. Degradation of the 26-mer in incubation aliquots
was monitored by RP-HPLC.
(TIFF)
Figure S2 Degradation and fragment analysis of the 26-mer
incubated with R. aeria. Gliadin 26-mer (250 mg/ml) was
incubation in a suspension of WSA-8 (R. aeria) cells (OD620 1.2).
Incubation aliquots removed after 0 h, 2 h and 5 h were analyzed
by RP-HPLC (A). Degradation peaks labeled 1 to 10 were
collected and sequenced by LC-ESI-MS/MS (B). Large solid
arrows: cleavage after XPQ; large dotted arrows: cleavage after Q
(except XPQ), small solid arrows: cleavage after QPY; small dotted
arrows: other cleavages.
(TIFF)
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